 100M revenue specialty pharmaceutical company on an accelerated path to profitability1 Company name change to Aytu BioPharma, Inc. becomes effective today Former Neos Therapeutics board members Beth P. Hecht and Gerald McLaughlin have joined the Aytu BioPharma board of directors ENGLEWOOD, CO ACCESSWIRE March 22, 2021 Aytu BioScience, Inc. NASDAQ:AYTU, a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the closing of its merger with Neos Therapeutics previously trading on Nasdaq under NEOS. 